Work

Early post-approval results of gene therapy for RPE65-mediated retinal dystrophy with Luxturna (voretigene neparvovec) at Massachusetts Eye and Ear

Year: 2019

Type: article

Source: Investigative Ophthalmology & Visual Science

Authors: Noam D. Rudnick, David Terrell, Carol Weigel-DiFranco, Jason Comander

Institution: Massachusetts Eye and Ear Infirmary

Language: English

Topic: Retinal Development and Disorders

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,850

OpenAlex ID: W3022620882

FWCI:

Cites:

Cited by: 2

Related to: 10